Menu
GeneBe

MED17

mediator complex subunit 17, the group of Mediator complex

Basic information

Region (hg38): 11:93784226-93814963

Previous symbols: [ "CRSP6" ]

Links

ENSG00000042429NCBI:9440OMIM:603810HGNC:2375Uniprot:Q9NVC6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Strong), mode of inheritance: AR
  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Strong), mode of inheritance: AR
  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Microcephaly, postnatal progressive, with seizures and brain atrophyARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic20950787

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MED17 gene.

  • not provided (418 variants)
  • Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly (55 variants)
  • Inborn genetic diseases (30 variants)
  • not specified (23 variants)
  • Intellectual disability (2 variants)
  • Microcephaly (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED17 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
182
clinvar
10
clinvar
192
missense
3
clinvar
71
clinvar
6
clinvar
1
clinvar
81
nonsense
19
clinvar
4
clinvar
1
clinvar
24
start loss
0
frameshift
15
clinvar
1
clinvar
16
inframe indel
0
splice donor/acceptor (+/-2bp)
7
clinvar
7
splice region
3
31
2
36
non coding
54
clinvar
35
clinvar
89
Total 34 15 72 242 46

Highest pathogenic variant AF is 0.0000394

Variants in MED17

This is a list of pathogenic ClinVar variants found in the MED17 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-93784261-C-T Likely benign (Mar 21, 2019)1211367
11-93784298-A-C Benign (Jul 26, 2018)1244461
11-93784345-C-T Likely benign (Aug 30, 2018)1194177
11-93784489-C-T Likely benign (Jul 07, 2018)1199486
11-93784504-C-T Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly • MED17-related disorder Likely benign (Apr 10, 2019)989497
11-93784511-A-G Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Uncertain significance (Apr 17, 2020)989498
11-93784518-C-G Uncertain significance (Oct 03, 2023)1445226
11-93784519-C-T Likely benign (Jun 13, 2021)1624290
11-93784521-G-T Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly • Inborn genetic diseases Uncertain significance (Nov 23, 2022)989499
11-93784522-G-C Likely benign (Oct 06, 2023)2102241
11-93784525-G-A Likely benign (Nov 23, 2020)1655140
11-93784528-C-G Likely benign (Jun 30, 2022)2012424
11-93784534-G-T Likely benign (Oct 14, 2023)1126947
11-93784537-G-A Likely benign (Dec 16, 2023)1081632
11-93784537-G-C Likely benign (Oct 03, 2021)1594823
11-93784537-G-T Likely benign (Sep 05, 2023)1123052
11-93784540-C-T Likely benign (Feb 04, 2022)1095404
11-93784558-C-T Likely benign (Dec 26, 2023)3021427
11-93784559-G-T Pathogenic (Feb 21, 2023)2818918
11-93784567-G-A Likely benign (Aug 22, 2023)2754303
11-93784570-C-T Likely benign (Oct 22, 2022)1590825
11-93784573-T-C Likely benign (Apr 03, 2021)1547377
11-93784582-C-A Likely benign (Aug 14, 2021)1590608
11-93784583-C-T Likely benign (Feb 11, 2022)1908161
11-93784600-G-T Likely benign (Jul 07, 2020)1118602

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MED17protein_codingprotein_codingENST00000251871 1230469
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.08e-90.9961257000471257470.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8782983440.8670.00001724263
Missense in Polyphen7190.4350.78511127
Synonymous0.5981161240.9320.000006131218
Loss of Function2.632037.30.5360.00000208395

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003950.000394
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0002850.000281
Middle Eastern0.000.00
South Asian0.0001630.000163
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.;
Pathway
Thyroid hormone signaling pathway - Homo sapiens (human);Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation (Consensus)

Recessive Scores

pRec
0.131

Intolerance Scores

loftool
0.864
rvis_EVS
-0.78
rvis_percentile_EVS
12.88

Haploinsufficiency Scores

pHI
0.0872
hipred
Y
hipred_score
0.715
ghis
0.619

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.768

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Med17
Phenotype

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;intracellular steroid hormone receptor signaling pathway;androgen receptor signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus;nucleoplasm;transcription factor complex;membrane;mediator complex;core mediator complex
Molecular function
transcription coregulator activity;transcription coactivator activity;protein binding;nuclear receptor transcription coactivator activity;signaling receptor activity;vitamin D receptor binding;thyroid hormone receptor binding